Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 29 January 2020. Neal Batra.

Executive Summary

By 2040, the health-care industry will see a major transformation where consumers enabled by digital technologies and open source, secure access to health data will be able to manage their own health, according to a Deloitte analysis. A panel of experts discussed Deloitte's vision for the future of health care during CES 2020. See what Neal Batra, a principal in Deloitte's Life Sciences and Health Care practice, said about it here.

"The explosion of granular, robust and individualized data and the ability to link disparate sources – through open source, secure platforms – allowing that data to come together, will drive this change and will create a holistic [and individualized] picture of our health through wearables and the next-generation 'always-on sensors' that are embedded in the devices around us." – Neal Batra, principal, Deloitte's Life Sciences and Health Care practice

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT126171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel